Sei Investments CO Zai Lab LTD Transaction History

Sei Investments CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $9.25 Million - $17.7 Million	-168,416 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$105.0 - $178.37 $6.83 Million - $11.6 Million	65,010 Added 62.87%	168,416 $17.7 Million
Q2 2021 Aug 06, 2021	BUY	$125.11 - $180.0 $10.8 Million - $15.6 Million	86,626 Added 516.25%	103,406 $18.3 Million
Q1 2021 May 12, 2021	BUY	$126.27 - $191.71 $2.12 Million - $3.22 Million	16,780 New	16,780 $2.24 Million

124

39.9M

41.2K

190K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $1.7B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.